Skip to main content

Imatinib Mesylate Tablets Shortage

Last Updated: May 14, 2025
Status: Current

Products Affected - Description
    • Imatinib mesylate oral tablet, Apotex, 100 mg, bottle, 90 count, NDC 60505-2900-09
    • Imatinib mesylate oral tablet, Apotex, 400 mg, bottle, 30 count, NDC 60505-2901-03
    • Imatinib mesylate oral tablet, Major, 400 mg, unit-dose blister pack, 30 count, NDC 00904-6621-04
    • Imatinib mesylate oral tablet, Teva, 100 mg, bottle, 90 count, NDC 00093-7629-98
    • Imatinib mesylate oral tablet, Teva, 400 mg, bottle, 30 count, NDC 00093-7630-56
    • Imatinib mesylate oral tablet, Upsher-Smith, 100 mg, bottle, 90 count, NDC 00832-0532-09
    • Imatinib mesylate oral tablet, Upsher-Smith, 400 mg, bottle, 30 count, NDC 00832-0533-03
Reason for the Shortage
    • Apotex did not provide a reason for the shortage.
    • Major did not provide a reason for the shortage.
    • Mylan (Viatris) has imatinib tablets available.
    • Novartis has Gleevec tablets available.
    • Sun discontinued imatinib tablets in December 2024.
    • Teva did not provide a reason for the shortage.
    • Upsher-Smith did not provide a reason for the shortage.
Available Products
    • Gleevec oral tablet, Novartis, 100 mg, bottle, 90 count, NDC 00078-0401-34
    • Gleevec oral tablet, Novartis, 400 mg, bottle, 30 count, NDC 00078-0649-13
    • Imatinib mesylate oral tablet, Major, 100 mg, unit-dose blister pack, 30 count, NDC 00904-6901-04
    • Imatinib mesylate oral tablet, Mylan (Viatris), 100 mg, bottle, 90 count, NDC 00378-2245-77
    • Imatinib mesylate oral tablet, Mylan (Viatris), 100 mg, unit-dose blister pack, 30 count, NDC 42292-0043-03
    • Imatinib mesylate oral tablet, Mylan (Viatris), 400 mg, bottle, 30 count, NDC 00378-2246-93
    • Imatinib mesylate oral tablet, Mylan (Viatris), 400 mg, unit-dose blister pack, 30 count, NDC 42292-0044-03

Estimated Resupply Dates

    • Apotex has imatinib tablets on back order and the company estimates a release date in late-May 2025.
    • Major has imatinib 400 mg tablets in 30 count unit-dose packages on back order and the company estimates a release date of early-June 2025.
    • Teva has imatinib tablets on back order and the company estimates a release date in early- to mid-July 2025.
    • Upsher-Smith has imatinib tablets on allocation for primary customers.

Updated

Created May 14, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer